Novo Nordisk A/S NOVO-B.CO DK Equity☆

Novo Nordisk A/S (Nasdaq Copenhagen: NOVO-B.CO) closed at 295.25 DKK, -3.2%, on 2026-08-27, with a trailing P/E of 13.2, a return on equity of 60.7%, a net margin of 33.1% and 3-year sales growth of 20.4%. Institutional ownership, earnings history and filed financials are on the tabs below.

Item 3 and Item 9A are read from original 10-Ks. Foreign filers (20-F / ESEF / EDINET) file none, so this read covers US SEC filers.